A Study to Evaluate the Safety, Tolerability, Drug Levels, Food, Formulation, and pH Effects on Relative Absorption of BMS-986465 and Its Active Derivative BMS-986464 in Healthy Participants
Conditions: Healthy Participants Interventions: Drug: BMS-986465; Other: Placebo; Drug: Pegasys; Drug: Famotidine Sponsors: Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials
VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B
Conditions: Chronic Hepatitis B Interventions: Drug: VIR-2218 and peginterferon alfa-2a Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2023 Category: Research Source Type: clinical trials
Interferon Alfa Therapy Based on Th17 Profile in Membranous Nephropathy
Condition: Membranous Nephropathy Intervention: Drug: Peginterferon Alfa-2A 180 MCG/ML Injectable Solution Sponsor: Centre Hospitalier Universitaire de Nice Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2023 Category: Research Source Type: clinical trials
Single Dose Escalation Study of P1101 in Healthy Adult Male Subjects
Condition: Healthy Volunteers Interventions: Drug: P1101 (24 mcg); Drug: P1101 (48 mcg); Drug: P1101 (90 mcg); Drug: P1101 (180 mcg); Drug: P1101 (225 mcg); Drug: P1101 (270 mcg); Drug: Pegasys Sponsor: PharmaEssentia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials
